Search alternatives:
significant male » significant main (Expand Search), significant cause (Expand Search), significant based (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant male » significant main (Expand Search), significant cause (Expand Search), significant based (Expand Search)
non decrease » nn decrease (Expand Search), point decrease (Expand Search), note decreased (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
161
The number of gauging cross-sections where a statistically significant decreasing trend was identified.
Published 2024“…<p>The number of gauging cross-sections where a statistically significant decreasing trend was identified.…”
-
162
-
163
-
164
-
165
<i>Trappc9</i> deficient mice show a decrease in brain weight and size.
Published 2020“…<p><b>(A)</b><i>Trappc9</i> deficient mice show a decrease in brain weight in a parent-of-origin manner. …”
-
166
-
167
-
168
-
169
Annual treatment frequencies in recurrence and non-recurrence groups.
Published 2025“…In the non-recurrence group, visits declined from 10.4 ± 4.5 preoperatively to 7.1 ± 2.2, 3.4 ± 1.3, and 2.6 ± 1.0 at 1, 2, and 3 years postoperatively, respectively (Kruskal-Wallis test, p < 0.001; <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0332941#pone.0332941.g008" target="_blank">Fig 8</a>).…”
-
170
-
171
-
172
A summary of the included study characteristics.
Published 2025“…There is no significant difference one month after NSPT in diabetic patients (SMD: -5.83, 95%CI: -15.5, 3.83, p = 0.237, I-square, 97.4%, random effects model, n = 2), but three (SMD: -2.44, 95%CI: -3.37, -1.15, p = 0.001, I-square, 75.9%, random effects model, n = 3) and six months (SMD: -2.41, 95%CI: -3.81, -1.01, p = 0.001, I-square, 78.7%, random effects model, n = 2) after the treatment, a significant decrease is observed in the mean GCF visfatin level. …”
-
173
-
174
-
175
-
176
-
177
Table_1_The Co-occurrence of Chronic Hepatitis B and Fibrosis Is Associated With a Decrease in Hepatic Global DNA Methylation Levels in Patients With Non-alcoholic Fatty Liver Dise...
Published 2021“…The co-occurrence of CHB and liver fibrosis in NAFLD patients was associated with a decrease in global DNA methylation levels.</p>…”
-
178
-
179
-
180